BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29670653)

  • 1. Dissecting the Evolving Risk of Relapse over Time in Surveillance for Testicular Cancer.
    Nayan M; Hamilton RJ
    Adv Urol; 2018; 2018():7182014. PubMed ID: 29670653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional risk of relapse in patients with germ cell testicular tumors: personalizing surveillance in clinical stage 1 disease.
    Goldberg H; Madhur N; Hamilton RJ
    Curr Opin Urol; 2018 Sep; 28(5):454-460. PubMed ID: 29916845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.
    Nayan M; Jewett MA; Hosni A; Anson-Cartwright L; Bedard PL; Moore M; Hansen AR; Chung P; Warde P; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
    Eur Urol; 2017 Jan; 71(1):120-127. PubMed ID: 27527805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Relapses in Stage I Testicular Cancer Patients on Surveillance.
    Mortensen MS; Lauritsen J; Kier MG; Bandak M; Appelt AL; Agerbæk M; Holm NV; Kempel MM; von der Maase H; Daugaard G
    Eur Urol; 2016 Aug; 70(2):365-71. PubMed ID: 26996661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant treatment for stage I of testicular germ cell tumours].
    Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
    Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.
    Francis R; Bower M; Brunström G; Holden L; Newlands ES; Rustin GJ; Seckl MJ
    Eur J Cancer; 2000 Oct; 36(15):1925-32. PubMed ID: 11000572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Treatment of Testicular Cancer: A Clinician's Perspective.
    Bernard B; Sweeney CJ
    Surg Pathol Clin; 2015 Dec; 8(4):717-23. PubMed ID: 26612223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.
    Weir HK; Marrett LD; Moravan V
    CMAJ; 1999 Jan; 160(2):201-5. PubMed ID: 9951441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatments for stage I testicular cancer.
    Nappi L; Nichols CR; Kollmannsberger CK
    Clin Adv Hematol Oncol; 2017 Aug; 15(8):626-631. PubMed ID: 28949950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
    Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
    J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance in stage I testicular seminoma - risk of late relapse.
    Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
    Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting the international trends in testicular seminoma and nonseminoma incidence.
    Bray F; Ferlay J; Devesa SS; McGlynn KA; Møller H
    Nat Clin Pract Urol; 2006 Oct; 3(10):532-43. PubMed ID: 17031378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy.
    Oliver RT; Ong J; Shamash J; Ravi R; Nagund V; Harper P; Ostrowski MJ; Sizer B; Levay J; Robinson A; Neal DE; Williams M;
    Urology; 2004 Mar; 63(3):556-61. PubMed ID: 15028457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.